*Refresh the page if the below document does not appear.
When pharma companies step over the line
Following a tax official search of a drugmaker’s premises and a Supreme Court petition from a group of medical representatives alleging unethical marketing tactics by drugmakers, the marketing strategies of pharmaceutical companies are being closely examined.
Spent less than Rs 10 crore on promotions, claims the maker of Dolo 650
Micro Labs, the maker of the Dolo 650, which is in the spotlight due to alleged unethical practices, claims to have spent a pittance – less than Rs 10 crore per year – on marketing and promotion of the brand.
Gilead Sciences receives European marketing approval for Sunlenca injection and tablets
Gilead Sciences announced that the European Commission (EC) has approved Sunlenca (lenacapavir) injection and tablets for the treatment of HIV infection in combination with other antiretroviral medications(s).
Epilepsy drug from Jazz Pharmaceuticals enters phase 3 trial
Epidiolex will be evaluated in phase 3 trials for 14 weeks in a randomized, double-blind, placebo-controlled study and expected to alleviate symptoms associated with Doose syndrome (EMAS), a rare type of childhood onset epilepsy that accounts for 1-2% of all cases.
PharmEasy withdraws its market listing strategy
The decision of India’s largest online pharmacy PharmEasy to cancel its listing plans highlights the difficulties that start-ups face when it comes to accessing public markets.
In New Drugs Bill 2022, SPO urges govt to increase the penalty for non-pharmacists dispensing medicines
Senior Pharmacists’ Organisation (SPO) in Kerala has asked the central government to increase the penalty for non-pharmacists dispensing medicines in the New Draft Bill 2022 for drug regulations.
UP FSDA sets up an optimum storage & sale limit of narcotic drugs & psychotropic substances
Food Safety and Drug Administration (FSDA)
Department in Uttar Pradesh has set a maximum
limit for the storage and sale of these substances
to drug dealers in an effort to reduce the abuse
of narcotic drugs and psychotropic substances
as intoxicants in the state.
